One Hundred-Twenty Second Meeting
Tuesday and Wednesday, May 20-21, 2014
Building 45, P2 Level, Conference Room E1/E2
Day-of-the-Meeting Contact Phone: 301-594-7008
TUESDAY, MAY 20
3:00 to 5:00 p.m. – This portion of the meeting is closed to the Public
This portion of the meeting is closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S. Code and Section 10(d) of the Federal Advisory Committee Act as amended (5 U.S.C. Appendix 2).
Review of Applications: Dr. Robin Barr
WEDNESDAY, MAY 21
8:00 a.m. to adjournment - This portion of the meeting is open to the Public
This meeting will be videocast 8:00 a.m. to 12:45 p.m.: http://videocast.nih.gov 
8:00 to 8:30 a.m.
Call to Order
Dr. Richard Hodes
- Director’s Status Report
Future Meeting Dates:
September 16-17, 2014 (Tues-Wed), Natcher Bldg.
January 27-28, 2015 (Tues – Wed), Natcher Bldg.
May 12-13, 2015 (Tues – Wed), Natcher Bldg.
- Consideration of Minutes of Last Meeting
8:30 to 8:45 a.m.
Report: Task Force on Minority Aging Research
Dr. Eliseo Perez-Stable
8:45 to 9:30 a.m.
Report: Working Group on Program
Dr. Richard Morimoto
- RFA/RFP Concept Clearance
9:30 to 10:15 a.m.
“Strategies for Expanding Scientific Workforce Diversity: A Focus on Faculty” — Dr. Hannah Valantine, Chief Officer for Scientific Workforce Diversity, OD/National Institutes of Health
10:15 to 10:30 a.m.
10:30 to 11:30 a.m.
- Program Highlights
10:30 to 11:00 a.m.
Program Highlights (DAB):
Dr. Felipe Sierra
“Measuring Molecular Aging” — Norman E. Sharpless, MD; Director, UNC Lineberger Comprehensive Cancer Center; Wellcome Distinguished Professor Cancer Research
11:00 to 11:30 a.m.
Program Highlights (DN):
Dr. Neil Buckholtz
“Genetic Analyses of Alzheimer’s Disease in Hispanics and African Americans” Dr. Richard Mayeux; Gertrude H. Sergievsky Professor of Neurology, Psychiatry and Epidemiology; Chair, Department of Neurology; Columbia University
11:30 to 12:45 p.m.
- Working Lunch
11:30 to 12:00 p.m.
Working Lunch: Program Highlights (DGCG):
Dr. Evan Hadley
“MsFLASH Trial 03 Results: Low-Dose Estradiol and the Serotonin-Norepinephrine Reuptake Inhibitor Venlafaxine for Vasomotor Sypmtoms” — Dr. Hadine Joffe, Harvard Medical School and Dana Farber Cancer Institute
12:00 a.m. to 12:15 p.m.
12:15 to 12:45 p.m.
Working Lunch: Program Highlights (DBSR):
Dr. Richard Suzman
"Evidence and Implications for Conscientiousness as a Marker of Health and Longevity” — Dr. Brent W. Robert;s Department of Psychology; University of Illinois, Urbana-Champaign